+44 (0) 1698 534002
Contact

News

BioAscent and AI drug discovery leader Exscientia publication builds on high-throughput screen (HTS) that identifies novel allosteric compounds

19 June 2023

A team at Exscientia, led by Martin Redhead and David Damerell, in collaboration with BioAscent, has published a paper e...

Read more

Selecting the right Contract Research Organisation

25 May 2023

With a growing demand for contract research organisation (CRO) services, it is increasingly challenging to identify the...

Read more

SPR in academia and industry

20 April 2023

BioAscent has experienced a growing demand for its SPR expertise in recent months.  In our latest blog, Dominika Kowalcz...

Read more

Demand for in silico discovery expertise increases

10 February 2023

With a 400% increase in new customer projects over the last year (2022), it’s safe to say that demand for BioAscent’s in...

Read more

Compound Management Shipping and Logistics: A look behind the scenes

06 February 2023

BioAscent is a science-led drug discovery CRO with expertise in medicinal and synthetic chemistry, computational chemist...

Read more

BioAscent reports major revenue growth in 2022

01 February 2023

BioAscent has reported significant growth in 2022 – the fourth successive year of high double-digit growth since becomin...

Read more

Utilising Project Management Skills for Drug Discovery

24 January 2023

At BioAscent, we work with customers to deliver complex projects to accomplish their drug discovery goals. Projects are...

Read more

Meet the Team: Dr Christopher Faulkner

17 January 2023

BioAscent’s growing reputation for computational chemistry expertise has led to a continued increase in demand from cust...

Read more

BioAscent promotes knowledge exchange through collaboration with University of Glasgow

09 December 2022

BioAscent has partnered with the University of Glasgow and Caldan Therapeutics to help support a Medical Research Scotla...

Read more

BioAscent recognised for exceptional performance

08 November 2022

BioAscent has been recognised for its exceptional performance in 2021.The laboratory-based drug-discovery contract resea...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact